Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 110 shares at $104.42 ($11K) on 2021-01-04, disclosed to the SEC on 2021-01-05.
Scheduled sale ($11k) by President Softgel & Oral Technology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |